The role of thyroid stimulating immunoglobulins of Graves's disease in neonatal thyrotoxicosis.

Suppr

超能文献

作者信息

Munro D S, Dirmikis S M, Humphries H, Smith T, Broadhead G D

出版信息

Br J Obstet Gynaecol. 1978 Nov;85(11):837-43. doi: 10.1111/j.1471-0528.1978.tb15839.x.

DOI:10.1111/j.1471-0528.1978.tb15839.x

PMID:581471

Abstract

摘要

相似文献

The role of thyroid stimulating immunoglobulins of Graves's disease in neonatal thyrotoxicosis.

Br J Obstet Gynaecol. 1978 Nov;85(11):837-43. doi: 10.1111/j.1471-0528.1978.tb15839.x.

Placental transmission of thyroid-stimulating immunoglobulins.促甲状腺素受体刺激性抗体的胎盘传递。

Br Med J. 1975 Jun 21;2(5972):665-6. doi: 10.1136/bmj.2.5972.665.

Neonatal hyperthyroidism and long-acting thyroid stimulator protector.新生儿甲状腺功能亢进症与长效甲状腺刺激素保护剂

Br Med J. 1974 Dec 21;4(5946):695-6. doi: 10.1136/bmj.4.5946.695.

Neonatal thyrotoxicosis is associated with transplacental passage of human thyroid stimulating immunoglobulin (HTSI).新生儿甲状腺毒症与人类甲状腺刺激免疫球蛋白（HTSI）经胎盘传递有关。

Arch Dis Child. 1976 Jul;51(7):565-7. doi: 10.1136/adc.51.7.565.

["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].["长效甲状腺刺激素"与新生儿甲状腺毒症中的促甲状腺激素]

Schweiz Med Wochenschr. 1968 Jan 6;98(1):8-12.

The role of long acting thyroid stimulator in neonatal thyrotoxicosis.

Clin Endocrinol (Oxf). 1972 Jan;1(1):81-90. doi: 10.1111/j.1365-2265.1972.tb00380.x.

Neonatal thyrotoxicosis with long acting thyroid stimulator-protector.伴有长效甲状腺刺激物-保护剂的新生儿甲状腺毒症

Ir Med J. 1977 Mar 31;70(4):124-5.

[Etiology of hyperthyroidism].

Schweiz Med Wochenschr. 1967 Oct 14;97(41):1342-52.

Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.一名患有桥本甲状腺炎、长效甲状腺刺激素（LATS）和LATS保护因子均为阴性但甲状腺刺激抗体阳性的女性所分娩的婴儿出现短暂性甲状腺毒症。

J Clin Endocrinol Metab. 1982 Feb;54(2):354-6. doi: 10.1210/jcem-54-2-354.

Neonatal thyrotoxicosis: a rare pediatric emergency.

Ann Emerg Med. 1980 Nov;9(11):585-7. doi: 10.1016/s0196-0644(80)80231-9.

引用本文的文献

Neonatal thyroid disorders.新生儿甲状腺疾病

Arch Dis Child Fetal Neonatal Ed. 2002 Nov;87(3):F165-71. doi: 10.1136/fn.87.3.f165.

Drug therapy for hyperthyroidism in pregnancy: safety issues for mother and fetus.妊娠期甲状腺功能亢进症的药物治疗：对母亲和胎儿的安全问题

Drug Saf. 2000 Sep;23(3):229-44. doi: 10.2165/00002018-200023030-00005.

Treatment of hyper- and hypothyroidism in pregnancy.妊娠期甲状腺功能亢进和减退的治疗。

J Endocrinol Invest. 1993 May;16(5):391-6. doi: 10.1007/BF03348864.

Autoimmune thyroid disease and pregnancy.自身免疫性甲状腺疾病与妊娠

Br Med J (Clin Res Ed). 1984 Jun 16;288(6433):1780-1. doi: 10.1136/bmj.288.6433.1780.

Serum long acting thyroid stimulator protector in pregnancy complicated by Graves' disease.妊娠合并格雷夫斯病时血清长效甲状腺刺激物保护剂

Br Med J (Clin Res Ed). 1983 Mar 19;286(6369):934-5. doi: 10.1136/bmj.286.6369.934.

Management of endocrine disorders in pregnancy Part I--thyroid and parathyroid disease.妊娠期内分泌疾病的管理第一部分——甲状腺和甲状旁腺疾病

Postgrad Med J. 1984 Apr;60(702):245-52. doi: 10.1136/pgmj.60.702.245.

Thyroid pertechnetate scan in neonatal hyperthyroidism.

Ir J Med Sci. 1982 Jan;151(1):22-3. doi: 10.1007/BF02940136.

Thyroid stimulating immunoglobulins. The Watson Smith lecture 1983.促甲状腺素受体抗体。1983年沃森·史密斯讲座

J R Coll Physicians Lond. 1984 Jul;18(3):155-60.

Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease.甲状腺刺激抗体的免疫球蛋白G抑制剂是新生儿Graves病发病延迟的一个原因。

J Clin Invest. 1983 Oct;72(4):1352-6. doi: 10.1172/JCI111091.

Absence of gradient of thyrotropin receptor antibody and T cell subset distribution between thyroid and peripheral venous blood in patients with Graves' disease prepared for surgery with carbimazole and potassium iodide.使用卡比马唑和碘化钾准备手术的Graves病患者甲状腺与外周静脉血中促甲状腺素受体抗体梯度及T细胞亚群分布的缺失

Clin Exp Immunol. 1988 Aug;73(2):265-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验